Cargando…

Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022

Detalles Bibliográficos
Autores principales: Prasad, Namrata, Derado, Gordana, Nanduri, Srinivas Acharya, Reses, Hannah E., Dubendris, Heather, Wong, Emily, Soe, Minn Minn, Li, Qunna, Dollard, Philip, Bagchi, Suparna, Edwards, Jonathan, Shang, Nong, Budnitz, Dan, Bell, Jeneita, Verani, Jennifer R., Benin, Andrea, Link-Gelles, Ruth, Jernigan, John, Pilishvili, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098239/
https://www.ncbi.nlm.nih.gov/pubmed/35511708
http://dx.doi.org/10.15585/mmwr.mm7118a4
_version_ 1784706338177155072
author Prasad, Namrata
Derado, Gordana
Nanduri, Srinivas Acharya
Reses, Hannah E.
Dubendris, Heather
Wong, Emily
Soe, Minn Minn
Li, Qunna
Dollard, Philip
Bagchi, Suparna
Edwards, Jonathan
Shang, Nong
Budnitz, Dan
Bell, Jeneita
Verani, Jennifer R.
Benin, Andrea
Link-Gelles, Ruth
Jernigan, John
Pilishvili, Tamara
author_facet Prasad, Namrata
Derado, Gordana
Nanduri, Srinivas Acharya
Reses, Hannah E.
Dubendris, Heather
Wong, Emily
Soe, Minn Minn
Li, Qunna
Dollard, Philip
Bagchi, Suparna
Edwards, Jonathan
Shang, Nong
Budnitz, Dan
Bell, Jeneita
Verani, Jennifer R.
Benin, Andrea
Link-Gelles, Ruth
Jernigan, John
Pilishvili, Tamara
author_sort Prasad, Namrata
collection PubMed
description
format Online
Article
Text
id pubmed-9098239
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-90982392022-05-19 Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 Prasad, Namrata Derado, Gordana Nanduri, Srinivas Acharya Reses, Hannah E. Dubendris, Heather Wong, Emily Soe, Minn Minn Li, Qunna Dollard, Philip Bagchi, Suparna Edwards, Jonathan Shang, Nong Budnitz, Dan Bell, Jeneita Verani, Jennifer R. Benin, Andrea Link-Gelles, Ruth Jernigan, John Pilishvili, Tamara MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-05-06 /pmc/articles/PMC9098239/ /pubmed/35511708 http://dx.doi.org/10.15585/mmwr.mm7118a4 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Prasad, Namrata
Derado, Gordana
Nanduri, Srinivas Acharya
Reses, Hannah E.
Dubendris, Heather
Wong, Emily
Soe, Minn Minn
Li, Qunna
Dollard, Philip
Bagchi, Suparna
Edwards, Jonathan
Shang, Nong
Budnitz, Dan
Bell, Jeneita
Verani, Jennifer R.
Benin, Andrea
Link-Gelles, Ruth
Jernigan, John
Pilishvili, Tamara
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022
title Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022
title_full Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022
title_fullStr Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022
title_full_unstemmed Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022
title_short Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022
title_sort effectiveness of a covid-19 additional primary or booster vaccine dose in preventing sars-cov-2 infection among nursing home residents during widespread circulation of the omicron variant — united states, february 14–march 27, 2022
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098239/
https://www.ncbi.nlm.nih.gov/pubmed/35511708
http://dx.doi.org/10.15585/mmwr.mm7118a4
work_keys_str_mv AT prasadnamrata effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT deradogordana effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT nandurisrinivasacharya effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT reseshannahe effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT dubendrisheather effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT wongemily effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT soeminnminn effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT liqunna effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT dollardphilip effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT bagchisuparna effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT edwardsjonathan effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT shangnong effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT budnitzdan effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT belljeneita effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT veranijenniferr effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT beninandrea effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT linkgellesruth effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT jerniganjohn effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022
AT pilishvilitamara effectivenessofacovid19additionalprimaryorboostervaccinedoseinpreventingsarscov2infectionamongnursinghomeresidentsduringwidespreadcirculationoftheomicronvariantunitedstatesfebruary14march272022